AC Immune SA
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. AC Immune SA's past years’ income statements indicate that its last revenue has increased compared to the previous period by 276% to $14,801,000. The net income raised on -$54,233,000 and profit margin reached -366%. Total operating expenses were $13,819,000.

Profit Margin

AC Immune SA (NASDAQ:ACIU): Profit margin
2014 30.26M 10.74M 35.5%
2015 39.09M 20.27M 51.85%
2016 23.21M -7.09M -30.57%
2017 20.25M -26.41M -130.39%
2018 7.19M -50.95M -708.24%
2019 111.02M 45.44M 40.93%
2020 15.43M -62.10M -402.47%
2021 0 -72.99M
2022 3.93M -70.75M -1798.04%
2023 14.80M -54.23M -366.41%

ACIU Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
14.80M3.93M015.43M111.02M7.19M20.25M23.21M39.09M30.26M
Cost of revenue
54.60M60.33M62.28M59.48M50.43M032.66M017.04M16.11M
Gross profit
-39.80M-56.40M-62.28M-44.05M60.59M7.19M-12.40M23.21M22.04M14.15M
Operating exp.
Research and development
54.60M60.33M62.28M59.48M50.43M44.27M32.66M25.77M17.04M16.11M
Selling and marketing
0000000000
Total operating expenses
13.81M74.78M79.01M76.69M66.49M56.74M42.79M33.67M20.46M19.55M
Operating income
-53.62M-70.84M-79.01M-61.26M44.53M-49.55M-22.53M-10.45M18.62M10.71M
Other income (expenses), net
-599K107K6.01M-661K906K-1.19M-3.87M3.36M1.64M27K
Income before tax
-54.22M-70.74M-72.99M-61.92M45.44M-50.95M-26.41M-7.09M20.27M10.74M
Income tax expense
10K13K3K184K1.89M-1.10M147K3.61M1.64M31K
Net income
-54.23M-70.75M-72.99M-62.10M45.44M-50.95M-26.41M-7.09M20.27M10.74M
Earnings per share
Basic EPS
-0.64-0.85-0.97-0.860.64-0.82-0.46-0.140.370.19
Diluted EPS
-0.64-0.85-0.97-0.860.64-0.82-0.46-0.140.370.19
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source